Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,681.20
+5.30 (0.32%)
Jan 28, 2026, 1:35 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 276.12 billion as of January 27, 2026. Its market cap has decreased by -9.41% in one year.
Market Cap
276.12B
Enterprise Value
247.12B
Revenue
58.01B
Ranking
n/a
PE Ratio
34.93
Stock Price
1,681.20
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 276.12B, a decrease of -7.06%. That is a compound annual growth rate of -1.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 276.12B | -2.68% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 555.29B |
| Laurus Labs | 548.71B |
| Ipca Laboratories | 371.12B |
| Ajanta Pharma | 337.15B |
| Emcure Pharmaceuticals | 290.20B |
| Wockhardt | 219.62B |
| Piramal Pharma | 201.05B |
| Eris Lifesciences | 191.94B |